FOXP3 and melanoma: Using NSG mice, HLA-A-matched CD34+ cells, fetal thymus and DNA-based vectors to provide human cytokines, Somasundaram et al. demonstrated that co-recruitment of mast cells and forkhead box P3 (FoxP3)+ regulatory T cells into melanomas was associated with resistance to anti-PD-1 therapy [211].